+499.5%
MRNA vs THC
+40.9%
+458.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.6% | -2.8% | -2.2% |
| 7D | +5.5% | -0.7% | +6.1% | +5.5% |
| 30D | +158.7% | +1.3% | +157.5% | +158.0% |
| 3M | +182.1% | +64.2% | +117.9% | +168.6% |
| 6M | +151.8% | +8.3% | +143.5% | +144.6% |
| YTD | +393.6% | +33.4% | +360.2% | +383.2% |
| 1Y | +499.5% | +37.7% | +461.8% | +484.7% |
| All | +499.5% | +40.9% | +458.6% | +484.7% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling